Jonathan Couchman

Insider Reports History

Identity Names, identifiers, and filing context for this profile. 1 identity field
Reporting-owner location
New York, NY
SEC source record Original filing metadata and source links for verification. 1 source field
Latest reporting-owner signature
/s/ Jon Couchman
Source: Latest parsed Forms 3/4/5 signature
Source evidence Original filing metadata and source links for verification. 1 source field
Transaction source note
Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for Jonathan Couchman

Form 4 holding 10%+ Owner

ENZON PHARMACEUTICALS, INC.

Security class
Common Stock, $0.01 par value
Shares / value
4,717,666
Estimated value
$665,191
Report date
13 Aug 2021
Price
$0.1410
Ownership
By Jonathan Couchman
Form 4 holding 10%+ Owner

ENZON PHARMACEUTICALS, INC.

Security class
Common Stock, $0.01 par value
Shares / value
2,043,024
Estimated value
$288,066
Report date
13 Aug 2021
Price
$0.1410
Ownership
By Xstelos Corp.
Form 4 holding 10%+ Owner

ENZON PHARMACEUTICALS, INC.

Security class
Common Stock, $0.01 par value
Shares / value
633,264
Estimated value
$89,290
Report date
13 Aug 2021
Price
$0.1410
Ownership
By Myrexis, Inc.
Form 4 holding 10%+ Owner

ENZON PHARMACEUTICALS, INC.

Security class
Common Stock, $0.01 par value
Shares / value
350,000
Estimated value
$49,350
Report date
13 Aug 2021
Price
$0.1410
Ownership
By Couchman Family Fund

Insider Reports Filed by Jonathan Couchman

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .